Portal de Periódicos da CAPES

An evidence‐based update of the use of analgesics in dentistry

2008; Wiley; Volume: 46; Issue: 1 Linguagem: Inglês

10.1111/j.1600-0757.2008.00225.x

1600-0757

Cliff K. S. Ong, Robin A Seymour,

Dental Anxiety and Anesthesia Techniques

Periodontology 2000Volume 46, Issue 1 p. 143-164 An evidence-based update of the use of analgesics in dentistry Cliff K. S. Ong, Cliff K. S. OngSearch for more papers by this authorRobin A. Seymour, Robin A. SeymourSearch for more papers by this author Cliff K. S. Ong, Cliff K. S. OngSearch for more papers by this authorRobin A. Seymour, Robin A. SeymourSearch for more papers by this author First published: 14 January 2008 https://doi.org/10.1111/j.1600-0757.2008.00225.xCitations: 19Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Band CJ, Band PR, Deschamps M, Besner JG, Coldman AJ. Human pharmacokinetic study of immediate-release (codeine phosphate) and sustained-release (codeine Contin) codeine. J Clin Pharmacol 1994: 34: 938– 943. 2 Barden J, Edwards JE, Collins SL, McQuay HJ, Moore RA. Single dose ibuprofen for postoperative pain. Oxford: The Cochrane Library Update Software, 2002. 3 Barden J, Edwards JE, McQuay HJ, Moore RA. Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol 2003: 3: 1. 4 Barden J, Edwards JE, McQuay HJ, Moore RA. Single dose oral celecoxib for postoperative pain. Cochrane Database Syst Rev 2003: 2: CD004233. 5 Barden J, Edwards JE, McQuay HJ, Wiffen PJ, Moore RA. Oral analgesics after third molar surgery – a systematic review of relative efficacy. Br Dent J 2004: 197: 407– 411. 6 Barden J, Edwards J, Moore A, McQuay H. Single dose oral paracetamol (acetaminophen) for postoperative pain. Cochrane Database Syst Rev 2004: 1: CD004602. 7 Barden J, Edwards J, Moore RA, McQuay HJ. Single dose oral diclofenac for postoperative pain. Cochrane Database Syst Rev 2004: 2: CD004768. 8 Bardiau FM. Postoperative pain management. Anesth Analg 2003: 96: 179– 185. 9 Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A. . Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med 2005: 165: 189– 192. 10 Beaver WT, Wallenstein SL, Rogers A, Houde RW. Analgesic studies of codeine and oxycodone in patients with cancer: comparison of oral with intramuscular codeine and of oral with intramuscular oxycodone. J Pharmacol Exp Ther 1978: 207: 92– 100. 11 Betancourt JW, Kupp LI, Jasper SJ, Farooqi OA. Efficacy of ibuprofen–hydrocodone for the treatment of postoperative pain after periodontal surgery. J Periodontol 2004: 75: 872– 876. 12 Blot WJ, McLaughlin JK. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding. J Epidemiol Biostat 2000: 5: 137– 142. 13 Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, for the VIGOR Study Group. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000: 343: 1520– 1528. 14 Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991: 325: 87– 91. 15 Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA, for the Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005: 352: 1092– 1102. 16 Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin S, Bombardier C, Weinblatt ME, Van Der Heijde D, Erdmann E, Laine L, MEDAL Steering Committee. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006: 368: 1771– 1781. 17 Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001: 345: 1809– 1817 18 Celik G, Erkekol FO, Bavbek S, Dursun B, Misirliqil Z. Long-term use and tolerability of cyclooxygenase-2 inhibitors in patients with analgesic intolerance. Ann Allergy Asthma Immunol 2005: 95: 33– 37. 19 Celik G, Pasaoglu G, Bavbek S, Abadoglu O, Dursun B, Mungan D, Misirligil Z. Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance. J Asthma 2005: 42: 127– 131. 20 Chan FK, Graham DY. Review article: prevention of nonsteroidal anti-inflammatory drug gastrointestinal complications – review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004: 19: 1051– 1061. 21 Chen LC, Elliott RA, Ashcroft DM. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control. J Clin Pharm Ther 2004: 29: 215– 29. 22 Collins SL, Moore RA, McQuay HJ, Wiffen PJ, Edwards JE. Single dose oral ibuprofen and diclofenac for postoperative pain. Cochrane Database Syst Rev 2000: 2: CD001548. 23 Cook RJ, Sackeet DL. . The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995: 310: 452– 454. 24 Cooper SA, Reynolds DC, Gallegos LT, Reynolds B, Larouche S, Demetriades J, Struble WE. A PK/PD study of ibuprofen formulations. Clin Pharmacol Ther 1994: 55: 126. 25 Coulthard P, Haywood D, Tai MA, Jackson-Leech D, Pleuvry BJ, Macfarlane TV. Treatment of postoperative pain in oral and maxillofacial surgery. Br J Oral Maxillofac Surg 2000: 38: 588– 592. 26 Dearmond B, Francisco CA, Lin JS, Huang FY, Halladay S, Bartziek RD, Skare KL. Safety profile of over-the-counter naproxen sodium. Clin Ther 1995: 17: 587– 601. 27 Desjardins PJ, Mehlisch DR, Chang DJ, Krupa D, Polis AB, Petruschke RA, Malmstrom K, Geba GP. The time to onset and overall analgesic efficacy of rofecoxib 50 mg: a meta-analysis of 13 randomized clinical trials. Clin J Pain 2005: 2: 241– 50. 28 Dione RA. Additive effects of oxycodone and ibuprofen for postoperative dental pain (abstract). J Dent Res 1986: 72: 186. 29 Dubois RN, Abramson SB, Crofford L. Cyclooxygenase in biology and disease. FASEB J 1998: 12: 1063– 1073. 30 Dubois RW, Melmed GY, Henning JM, Laine L. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther 2004: 19: 197– 208. 31 Edwards JE, Loke YK, Moore RA, McQuay HJ. Single dose piroxicam for acute postoperative pain. Cochrane Database Syst Rev 2000: 4: CD002762. 32 Edwards JE, McQuay HJ, Moore RA. Single dose dihydrocodeine for acute postoperative pain. Cochrane Database Syst Rev 2000: 4: CD002760. 33 Edwards JE, Moore RA, McQuay HJ. Single dose oxycodone and oxycodone plus paracetamol (acetominophen) for acute postoperative pain. Cochrane Database Syst Rev 2000: 4: CD002763. 34 Edwards JE, Moore RA, McQuay HJ. Individual patient meta-analysis of single-dose rofecoxib in postoperative pain. BMC Anesthesiol 2004: 4: 3. 35 Elia N, Lysakowski C, Tramer MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone?. Meta-analyses of randomized trials. Anesthesiology 2005: 103: 1296– 1304. 36 Ervens J, Schiffmann L, Berger G, Hoffmeister B. Colon perforation with acute peritonitis after taking clindamycin and diclofenac following wisdom tooth removal. J Craniomaxillofac Surg 2004: 32: 330– 334. 37 Ettlin DA, Ettlin A, Bless K, Puhan M, Bernasconi C, Tillmann HC, Palla S, Gallo LM. Ibuprofen arginine for pain control during scaling and root planing: a randomized, triple-blind trial. J Clin Periodontol 2006: 33: 345– 350. 38 Ferreira SH. Peripheral analgesia: mechanism of the analgesic action of aspirin-like drugs and opiate-antagonists. Br J Pharmacol 1980: 49: 86– 97. 39 Forbes JA. Oral surgery. In: MB Max, RK Portenoy, EM Laska editors. Advances in Pain Research and Therapy: The Design of Analgesic Clinical Trials. New York: Raven Press, 1991: 347– 374. 40 Forbes JA, Keller CK, Smith JW, Zeleznock JR, Sevelius H, Beaver WT. Analgesic effect of naproxen sodium, codeine, a naproxen-codeine combination and aspirin on postoperative pain of oral surgery. Pharmacotherapy 1986: 6: 211– 218. 41 Fricke JR Jr, Hewitt DJ, Jordan DM, Fisher A, Rosenthal NR. A double-blind placebo-controlled comparison of tramadol/acetaminophen and tramadol in patients with postoperative dental pain. Pain 2004: 109: 250– 257. 42 Furberg C, Psaty B, FitzGerald GA. Parecoxib, valdecoxib, and cardiovascular risk [editorial]. Circulation 2005: 111: 249. 43 Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006: 174: 1589– 1594. 44 Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs: a metaanalysis. Ann Intern Med 1991: 115: 787– 796. 45 Gallardo F, Rossi E. Analgesic efficacy of flurbiprofen as compared to acetaminophen and placebo after periodontal surgery. J Periodontol 1990: 61: 224– 227. 46 Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998: 158: 33– 39. 47 Garcia Rodriguez LA, Gonzalez-Perez A. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med 2005: 3: 17. 48 Garcia Rodriquez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994: 343: 769– 772. 49 Giglio JA, Laskin DM. Double-blind comparison of meclofenamate sodium plus codeine, meclofenamate sodium, codeine, and placebo for relief of pain following surgical removal of third molars. J Oral Maxillofac Surg 1990: 48: 785– 790. 50 Gordon SM, Brahim JS, Rowan J, Kent A, Dionne RA. Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model. Clin Pharmacol Ther 2002: 72: 175– 183. 51 Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B, NSAID-Associated Gastric Ulcer Prevention Study Group. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active-and placebo-controlled study of misoprostol vs lansoprazole. Arch Intern Med 2002: 162: 169– 175. 52 Hagen NA, Babul N. Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer 1997: 79: 1428– 1437. 53 Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal anti-inflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998: 338: 727– 734. 54 Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996: 312: 1563– 1566. 55 Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000: 160: 2093– 2099. 56 Hersh EV, Moore PA, Ross GL. Over-the-counter analgesics and antipyretics: a critical assessment. Clin Ther 2000: 22: 500– 548. 57 Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case–control analysis. Br Med J 2005: 330: 1366. 58 Hunt RH, Harper S, Watson DJ, Yu C, Quan H, Lee M, Evans JK, Oxenius B. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. Am J Gastroenterol 2003: 98: 1725– 1733. 59 Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. Br J Anaesth 2002: 88: 199– 214. 60 Jeske AH. Selecting new drugs for pain control. J Am Dent Assoc 2002: 133: 1052– 1056. 61 Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004: 364: 2021– 2029. 62 Keating GM. Tramadol sustained-release capsules. Drugs 2006: 66: 223– 230. 63 Kloostra PW, Eber RM, Wang HL, Inglehart MR. Surgical versus non-surgical periodontal treatment: psychosocial factors and treatment outcomes. J Periodontol 2006: 77: 1253– 1260. 64 Kuehn BM. FDA panel: keep COX-2 drugs on market: black box for COX-2 labels, caution urged for all NSAIDs. JAMA 2005: 293: 1571– 1572. 65 Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiodt FV, Ostapowicz G, Shakil AO, Lee WM, Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005: 42: 1364– 1372. 66 Le Parc JM, Van Ganse E, Moore N, Wall R, Schneid H, Verriere F. Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients. Clin Rheumatol 2002: 21: 28– 31. 67 Lewis JD, Kimmel SE, Localio AR, Metz DC, Farrar JT, Nessel L, Brensinger C, McGibney K, Strom BL. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 2005: 129: 1865– 1874. 68 Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clin Ther 2005: 27: 418– 429. 69 MacDonald TM, Morant SV, Robinson GC, Shield MJ, McGilchrist MM, Murray FE, McDevitt DG. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. Br Med J 1997: 315: 1333– 1337. 70 MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003: 361: 573– 574. 71 Mason L, Edwards JE, Moore RA, McQuay HJ. Single dose oral naproxen and naproxen sodium for acute postoperative pain. Cochrane Database Syst Rev 2004: 4: CD004234. 72 McQuay HJ, Carroll D, Watts PG, Juniper RP, Moore RA. Codeine 20 mg increases pain relief from ibuprofen 400 mg after third molar surgery. A repeat-dosing comparison of ibuprofen and an ibuprofen–codeine combination. Pain 1989: 37: 7– 13. 73 McQuay H, Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl 2003: 28: 19– 22. 74 Medve RA, Wang J, Karim R. Tramadol and acetaminophen tablets for dental pain. Anesth Prog 2001: 48: 79– 81. 75 Mehlisch DR, Markenson J, Schnitzer TJ. The efficacy of nonsteroidal anti-inflammatory drugs for acute pain. Cancer Control 1999: 2 (Suppl. 1): 5– 9. 76 H Merskey, N Bogduk (eds). Classification of chronic pain – descriptions of chronic pain syndromes and definitions of pain terms, 2nd edn. Seattle: IASP Press, 1994: 40– 43. 77 Milsom I, Minic M, Dawood MY, Akin MD, Spann J, Niland NF, Squire RA. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther 2002: 24: 1384– 1400. 78 Moiniche S, Romsing J, Dahl JB, Tramer MR. NSAIDs and the risk of operative site bleeding after tonsillectomy: a quantitative systematic review. Anesth Analg 2003: 96: 68– 77. 79 Moling O, Cairon E, Rimenti G, Rizza F, Pristera R, Mian P. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther 2006: 28: 755– 760. 80 Moore A, Collins S, Carroll D, McQuay H. Paracetamol with and without codeine in acute pain: a quantitative systematic review. Pain 1997: 70: 193– 201. 81 Moore A, Collins S, Carroll D, McQuay H, Edwards J. Single dose paracetamol (acetaminophen), with and without codeine, for postoperative pain. Cochrane Database Syst Rev 2000: 2: CD001547. 82 Moore RA, McQuay HJ. Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997: 69: 287– 94. 83 Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005: 7: R1046– 1051. 84 Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically-applied non-steroidal anti-inflammatory drugs. Br Med J 1998: 316: 333– 338. 85 Nielsen GL, Sorensen HT, Mellemkjoer L, Blot WJ, McLaughlin JK, Tage-Jensen U, Olsen JH. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 2001: 111: 541– 545. 86 Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005: 352: 1081– 1091. 87 O’Brien TP, Roszkowski MT, Wolff LF, Hinrichs JE, Hargreaves KM. Effect of a non-steroidal anti-inflammatory drug on tissue levels of immunoreactive prostaglandin E2, immunoreactive leukotriene, and pain after periodontal surgery. J Periodontol. 1996: 67: 1307– 1316. 88 Olson NZ, Otero AM, Marrero I, Tirado S, Cooper S, Doyle G, Jayawardena S, Sunshine A. Onset of analgesia for liquigel ibuprofen 400 mg, acetaminophen 1000 mg, ketoprofen 25 mg, and placebo in the treatment of postoperative dental pain. J Clin Pharmacol 2001: 41: 1238– 1247. 89 Ong KS, Lirk P, Seymour RA, Jenkins BJ. Efficacy of pre-emptive analgesia for acute postoperative pain: a meta-analysis. Anesth Analg 2005: 100: 757– 772. 90 Ong KS, Lirk P, Tan CH, Seymour RA. An evidence update for NSAIDs. Clin Med Res 2007: 5: 19– 34. 91 Ong KS, P Lirk, Tan JML, Sow BSW. The analgesic efficacy of intravenous versus oral tramadol for preventing postoperative pain after third molar surgery. J Oral Maxillofac Surg 2005: 63: 1162– 1168. 92 Ong KS, Seymour RA. Maximising the safety of NSAID use in post-operative dental pain: an evidence-based approach. Anesth Prog 2003: 50: 62– 74. 93 Ong KS, Seymour RA. Pathogenesis of post-operative oral surgical pain. Anesth Prog 2003: 50: 5– 17. 94 Ong KS, Seymour RA, Chen FG, CL Ho. Preoperative ketorolac has a pre-emptive effect for postoperative third molar surgical pain: a randomized controlled trial. Int J Oral Maxillofac Surg 2004: 33: 771– 776. 95 Ong KS, Seymour RA, Tan JML. Sedation with midazolam leads to lower pain experience after third molar surgery: a randomized controlled trial. Anesth Analg 2004: 98: 1204– 1209. 96 Ong KS, Seymour RA, Yeo JF, Ho KH, Lirk P. The efficacy of preoperative versus postoperative rofecoxib for preventing acute postoperative dental pain: a prospective randomized crossover study using bilateral symmetrical oral surgery. Clin J Pain 2005: 21: 536– 542. 97 Ong KS, Tan JML. Preoperative intravenous tramadol versus ketorolac for preventing postoperative pain after third molar surgery. Int J Oral Maxillofac Surg 2004: 33: 274– 278. 98 Orlando A, Marrone C, Nicoli N, Tamburello G, Rizzo A, Pagliaro L, Cottone M, D'Amico G. Fatal necrotising fasciitis associated with intramuscular injection of nonsteroidal anti-inflammatory drugs after uncomplicated endoscopic polypectomy. J Infect 2007: 54: e145– 148. 99 Ott E, Nussmeier NA, Duke PC, Feneck RO, Alston RP, Snabes MC, Hubbard RC, Hsu PH, Saidman LJ, Mangano DT, Multicenter Study of Perioperative Ischemia (McSPI) Research Group; Ischemia Research, Education Foundation (IREF) Investigators. Efficacy and safety of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2003: 125: 1481– 1492. 100 Oxford League Table of Analgesic Efficacy. http://www.jr2.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/Leagtab.html (Accessed September2006). 101 Packman B, Packman E, Doyle G, Cooper S, Ashraf E, Koronkiewicz K, Jayawardena S. Solubilized ibuprofen: evaluation of onset, relief, and safety of a novel formulation in the treatment of episodic tension-type headache. Headache 2000: 40: 561– 567. 102 Pearlman B, Boyatzis S, Daly C, Evans R, Gouvoussis J, Highfield J, Kitchings S, Liew V, Parsons S, Serb P, Tseng P, Wallis C. The analgesic efficacy of ibuprofen in periodontal surgery: a multi-centre study. Aust Dent J 1997: 42: 328– 334. 103 Petersen JK, Hansson F, Strid S. The effect of an ibuprofen–codeine combination for the treatment of patients with pain after removal of lower third molars. J Oral Maxillofac Surg 1993: 51: 637– 640. 104 Picado P. COX-2 specific inhibitors in NSAID-intolerant patients. Int J Immunopathol Pharmacol. 2003: 16 (Suppl.): 11– 16. 105 Pihlstrom BL, Hargreaves KM, Bouwsma OJ, Myers WR, Goodale MB, Doyle MJ. Pain after periodontal scaling and root planing. J Am Dent Assoc 1999: 130: 801– 807. 106 Pillans PI, O’Connor N. Tissue necrosis and necrotizing fasciitis after intramuscular administration of diclofenac. Ann Pharmacother 1995: 29: 264– 266. 107 Po AL, Zhang WY. Analgesic efficacy of ibuprofen alone and combination with codeine or caffeine in post-surgical pain: a meta-analysis. Eur J Clin Pharmacol 1998: 53: 303– 311. 108 Raber M, Hofmann S, Junge K, Momberger H, Kuhn D. Analgesic efficacy and tolerability of Tramadol 100 mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clin Drug Invest 1999: 17: 415– 423. 109 Ramey DR, Watson DJ, Yu C, Bolognese JA, Curtis SP, Reicin AS. The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Curr Med Res Opin 2005: 21: 715– 722. 110 Rampal P, Moore N, Van Ganse E, Le Parc JM, Wall R, Schneid H, Verriere F. Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses. J Int Med Res 2002: 30: 301– 308. 111 Romsing J, Moiniche S. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta Anaesthesiol Scand 2004: 48: 525– 546. 112 Roszkowski MT, Swift JQ, Hargreaves KM. Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars. Pain 1997: 73: 339– 345. 113 Savage MG, Henry MA. Preoperative nonsteroidal anti-inflammatory agents: review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 2004: 98: 146– 152. 114 Scheiman JM, Fendrick AM. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs. Arthritis Res Ther 2005: 7 (Suppl. 4): S23– S29. 115 Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ, TARGET Study Group. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet 2004: 364: 665– 674. 116 Seymour RA, Walton JG. Pain control after third molar surgery. Int J Oral Sug 1984: 13: 457– 485. 117 Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000: 284: 1247– 1255. 118 Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman M, Geis GS. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995: 123: 241– 249. 119 Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 2006: 119: 255– 266. 120 Singh G, Wu O, Langhorne P, Madhok R. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther 2006: 8: R153. 121 Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M, Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005: 352: 1071– 1080. 122 Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, Feldman H, Kimmel S, Carson JL. Parental ketorolac and risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA 1996: 275: 376– 382. 123 Swift JQ, Garry MG, Roszkowski MT, Hargreaves KM. Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain. J Oral Maxillofac Surg 1993: 51: 112– 116. 124 Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006: 1: CD004257. 125 Tramer M, Williams J, Carroll D. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesth Scand 1998: 42: 71– 79. 126 Treede RD, Meyer RA, Raja SN, Campbell JN. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992: 38: 397– 421. 127 Trombelli L, Schincaglia GP, Zangari F, Scapoli C, Calura G. Effect of pretreatment with ketorolac tromethamine on post-operative pain following periodontal surgery. J Clin Periodontol 1996: 23: 128– 132. 128 Tucker PW, Smith JR, Adams DF. A comparison of 2 analgesic regimens for the control of postoperative periodontal discomfort. J Periodontol 1996: 67: 125– 129. 129 Varga EV, Yamamura HI, Rubenzik MK, Stropova D, Navratilova E, Roeske WR. Molecular mechanisms of excitatory signaling upon chronic opioid agonist treatment. Life Sci 2003: 74: 299– 311. 130 Vogel RI, Desjardins PJ, Major KV. Comparison of presurgical and immediate postsurgical ibuprofen on postoperative periodontal pain. J Periodontol 1992: 63: 914– 918. 131 Wall PD. The prevention of postoperative pain. Pain 1988: 33: 289– 290. 132 Wallace JL, Reuter BK, McKnight W, Bak A. Selective inhibitors of cyclooxygenase-2: are they really effective, selective, and GI-safe? J Clin Gastroenterol 1998: 27 (Suppl. 1): S28– S34. 133 Walton GM, Rood JP. A comparison of ibuprofen and ibuprofen–codeine combination in the relief of post-operative oral surgery pain. Br Dent J 1990: 169: 245– 247. 134 White WB, Faich G, Borer JS, Makuch RW. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am J Cardiol 2003: 92: 411– 418. 135 Williams HJ, Ward JR, Egger MJ, Neuner R, Brooks RH, Clegg DO, Field EH, Skosey JL, Alarcon GS, Willkens RF, Paulus HE, Russell IJ, Sharp JT. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993: 36: 1196– 1206. 136 Wolfe MM, Lichtensein DR, Singh G. Medical Progress: Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999: 340: 1888– 1899. 137 Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000: 288: 1765– 1769. 138 Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, Van Rensburg CJ, Swannell AJ, Hawkey CJ. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal anti-inflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998: 338: 719– 726. 139 Zuniga JR, Phillips CL, Shugars D. Analgesic safety and efficacy of diclofenac sodium softgels on postoperative third molar extraction pain. J Oral Maxillofac Surg 2004: 62: 806– 815. Citing Literature Volume46, Issue1February 2008Pages 143-164 ReferencesRelatedInformation